Search

Your search keyword '"Clifford, Steven C"' showing total 563 results

Search Constraints

Start Over You searched for: Author "Clifford, Steven C" Remove constraint Author: "Clifford, Steven C"
563 results on '"Clifford, Steven C"'

Search Results

1. Author Correction: Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage

2. Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage

4. Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups

5. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

6. Combining multi-site Magnetic Resonance Imaging with machine learning predicts survival in paediatric brain tumours

8. Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging

11. Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa—Results of the HIT 2000 trial.

12. In vivo modelling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastoma

16. EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

17. Cytogenetic prognostication within medulloblastoma subgroups.

18. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.

19. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

24. Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity

26. Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome

28. ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

29. Medulloblastoma

30. Supplementary Table S3 from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

31. Supplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

32. Supplementary Figure Legends from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

33. Supplementary Data from Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma

34. Supplementary Data from Rapid Diagnosis of Medulloblastoma Molecular Subgroups

45. Additional file 2 of Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging

47. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Approaches: An International Cohort Study

48. How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?

49. Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Catalog

Books, media, physical & digital resources